Skip to main content
Signal8

ALEXANDER MARGARET A.

SEC insider (Form 3/4/5 filer). CIK 0002036798. President and CEO at Ovid Therapeutics Inc. (OVID). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.

Companies ALEXANDER MARGARET A. has filed insider reports for

  • Ovid Therapeutics Inc. (OVID): Director, Officer, President and CEO
ALEXANDER MARGARET A. profile photo

ALEXANDER MARGARET A.

CIK: 0002036798

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ovid Therapeutics Inc. logo
OVID

Ovid Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Feb 26, 2026
    Award

    Employee Stock Option (Right to Buy)

    Direct
    1.4M shares-
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Feb 23, 2026
    Sale
    Direct
    11.7K shares at avg. $1.45$17K
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Jan 4, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    890K shares-
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Feb 26, 2025
    Sale
    Direct
    5.3K shares at avg. $0.56$3K
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Feb 20, 2025
    Award
    Direct
    43.8K shares-
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Jan 27, 2025
    Purchase
    Direct
    6.8K shares at avg. $0.73$5K
  • Ovid Therapeutics Inc. logo
    OVID

    Ovid Therapeutics Inc.

    Sep 9, 2024
    Award

    Employee Stock Option (right to buy)

    Direct
    140K shares-

1-7 of 7